Clinical effect of 125I seed implantation guided by enhanced CT-ultrasound fusion imaging in the treatment of locally recurrent malignant tumor of the head and neck

ZHU Ling-lin; ZHANG Yu; JI Yong-shuo; ZHU Jun-qiu; ZHU Yan-fei; LIU Yu-mei; ZHAO Hong

您当前的位置：

首页 >

文章列表页 >

Clinical effect of 125I seed implantation guided by enhanced CT-ultrasound fusion imaging in the treatment of locally recurrent malignant tumor of the head and neck

更新时间：2022-06-24

- Clinical effect of 125I seed implantation guided by enhanced CT-ultrasound fusion imaging in the treatment of locally recurrent malignant tumor of the head and neck
- null Issue 10, Pages: 899(2021)
- 作者机构：
  
  1. 复旦大学附属华东医院肿瘤科,上海,200040
  2. 上海具益门诊部,上海,201106
- 作者简介：
- 基金信息：
- DOI：
  CLC：
扫描看全文
ZHU Ling-lin, ZHANG Yu, JI Yong-shuo, et al. Clinical effect of 125I seed implantation guided by enhanced CT-ultrasound fusion imaging in the treatment of locally recurrent malignant tumor of the head and neck. [J]. null (10):899(2021)
DOI：

ZHU Ling-lin, ZHANG Yu, JI Yong-shuo, et al. Clinical effect of 125I seed implantation guided by enhanced CT-ultrasound fusion imaging in the treatment of locally recurrent malignant tumor of the head and neck. [J]. null (10):899(2021) DOI：

摘要

目的评估增强CT-超声融合成像引导125I粒子植入治疗局部复发性头颈部恶性肿瘤的临床疗效。方法将54例〖JP〗头颈部恶性肿瘤局部复发患者随机分为融合成像组（27例）和单一成像组（27例），分别采用增强CT-超声融合成像引导125I粒子植入治疗和单纯超声成像引导125I粒子植入治疗。比较2组患者90%靶体积所接受的剂量（D90）、靶区接受90%处方剂量的体积百分比（V90）、粒子补种率、粒子植入时间和粒子植入相关不良反应。结果融合成像组和单一成像组的D90、V90比较，差异有统计学意义（P<0.05）；融合成像组的粒子补种率低于单一成像组（P<0.05）；融合成像组的粒子植入时间长于单一成像组（P<0.05）；术后2组患者局部皮下血肿、急性放射损伤等不良反应发生率比较，差异均无统计学意义(P＞0.05)。结论增强CT-超声融合成像引导125I粒子植入治疗局部复发性头颈部恶性肿瘤的剂量分布更加合理，补种率低，可有效提高粒子植入精准性。

Abstract

关键词

头颈部肿瘤复发肿瘤125I粒子增强CT-超声融合成像

Keywords

tumor of the head and neckrecurrent tumor125I seedenhanced CT-ultrasound fusion imaging

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰